SSP

Two new SSPs issued for Estraderm MX® patches

The Department of Health and Social Care (DHSC) has issued two Serious Shortage Protocols for Estraderm MX® 25 microgram and 100microgram patches in response to a significant ongoing supply disruption.

SSP035 for Estraderm MX® 25 microgram patch will be in operation from Thursday 8th September 2022 until Friday 16th September 2022.

It allows Evorel® 25 microgram patches to be supplied against prescriptions for Estraderm MX® 25 microgram patches.

For more information

SSP036 for Estraderm MX® 100 microgram patch will be in operation from Thursday 8th September 2022 until Friday 16th September 2022.

It allows Evorel® 100 microgram patches to be supplied against prescriptions for Estraderm MX® 100 microgram patches.

For more information

 

There are no SSPs in place for Estraderm MX® 50mcg patches and 75mcg patches as these strengths are not affected by supply disruptions and should continue to be dispensed in accordance with the prescriptions.

The SSP035 and SSP036 only allow substitution of Estraderm MX®25 or 100 patches with Evorel® 25 or 100 patches, respectively and do not allow for the quantity supplied to be less than that prescribed.

The supervising pharmacist should ensure that the patient’s prescriber is notified when supplying a patient in accordance with these SSPs